Coldstream Capital Management Inc Revolution Medicines, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
300Shares Held
181MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$655 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$534 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$529 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$465 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$402 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.46B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...